Brevan Howard Capital Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$475K Sell
24,368
-78,587
-76% -$1.56M ﹤0.01% 1474
2026
Q1
$1.98M Buy
102,955
+33,962
+49% +$669K 0.02% 564
2025
Q4
$1.31M Buy
68,993
+51,371
+292% +$952K 0.01% 651
2025
Q3
$328K Buy
+17,622
New +$329K ﹤0.01% 1520
2024
Q4
Sell
-36,611
Closed -$681K 1383
2024
Q3
$681K Buy
+36,611
New +$617K ﹤0.01% 590
2024
Q1
Sell
-16,550
Closed -$236K 1314
2023
Q4
$236K Buy
+16,550
New +$235K ﹤0.01% 818

Other funds holding SBRA

Brevan Howard Capital Management's SBRA Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Sabra Healthcare REIT (SBRA) stake by 76% in Q2 2026, selling an estimated $1.56M and leaving 24,368 shares worth $475K. The position accounts for ﹤0.01% of the portfolio, ranked #1474.

Brevan Howard Capital Management first reported a position in SBRA in Q4 2023 and has held it in 6 quarters since. The position peaked at $1.98M in Q1 2026. 463 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Brevan Howard Capital Management held 24,368 shares of Sabra Healthcare REIT worth $475K as of Q2 2026.
  • Brevan Howard Capital Management sold 78,587 Sabra Healthcare REIT shares in Q2 2026, an estimated $1.56M.
  • Sabra Healthcare REIT made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1474 holding.
  • Brevan Howard Capital Management first reported a position in Sabra Healthcare REIT in Q4 2023 and has held it in 6 quarters since.
  • Brevan Howard Capital Management's Sabra Healthcare REIT position peaked at $1.98M in Q1 2026.
  • 463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.